Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Foundation Medicine's FoundationOne Tests

Premium

Foundation Medicine has received approval from New York State Department of Health for its FoundationOne and Foundation One Heme tests, which use next-generation sequencing to analyze cancer mutations in solid and hematological tumors, respectively. The tests had previously been offered under conditional approval to physicians.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.